Background
This article provides an overview of a market research report published by Credence Research. This report focuses on the current trends and future forecasts for the cell therapy consumables market up to 2032, analyzing the key drivers and technological innovations shaping market growth.
Key Findings
- The cell therapy consumables market is projected to reach a market size of $7.53 billion by 2032, driven by the increasing global adoption of advanced cell therapies such as CAR-T cell therapies, stem cell therapies, and induced pluripotent stem cell (iPSC) therapies.
- A primary driver of market growth is the rapid advancement of automation in cell therapy manufacturing. Automated systems improve manufacturing consistency, efficiency, and reproducibility, while reducing labor costs and contamination risks.
- The increasing use of closed-system consumables is also a significant booster for market growth. Closed systems are crucial for minimizing contamination risks from the external environment and maintaining a GMP (Good Manufacturing Practice)-compliant manufacturing environment.
- Demand for GMP-grade cell culture media, reagents, and kits is growing. These are indispensable components for ensuring the quality and safety of cell therapy products.
- Lonza’s Cocoon® platform and Miltenyi Biotec’s CliniMACS® Prodigy® system are specifically mentioned as key technological solutions supporting this market growth, serving as automated closed-system cell processing systems. These platforms address challenges in point-of-care and large-scale manufacturing of cell therapies.
About the Publisher
Credence Research is a global market research firm that provides detailed market analysis, forecasts, and strategic insights across a wide range of industrial sectors. They specialize in offering data-driven information to help corporate decision-makers establish a competitive advantage.
Source: #
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime

Comments